Approval · Notice of Compliance 18790 · 2016
ZOLMITRIPTAN: Notice of Compliance 18790
Issued December 19, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18790
- Date
- December 19, 2016
- Company
- CellChem Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- ZOMIG (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLMITRIPTAN | 02458780 | Cancelled Post Market |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB